Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/ , and follow us on X , LinkedIn and Facebook .
In Dyne Therapeutics’s own words, from its job postings.
| Team | Open roles | Typical posted pay (US) |
|---|---|---|
| Ops | 6 | $222K–$258K |
| Engineering | 2 | — |
| Finance | 2 | — |
Based on 10 US job postings from Dyne Therapeutics that disclose pay, the median posted range is $200K–$230K base salary. Ranges come straight from the job descriptions (pay-transparency disclosures), not from self-reported surveys.